Loes A M Leenen1, Ben F M Wijnen2, Reina J A de Kinderen3, Caroline M van Heugten4, Silvia M A A Evers5, Marian H J M Majoie6. 1. CAPHRI School for Public Health and Primary Care, Maastricht University, Maastricht, The Netherlands; Department of Health Services Research, Maastricht University, Maastricht, The Netherlands; Department of Research & Development, Epilepsy Centre Kempenhaeghe, Heeze, The Netherlands; Department of Neurology, Academic Centre for Epileptology, Epilepsy Centre Kempenhaeghe & Maastricht University Medical Centre, The Netherlands. Electronic address: leenenl@kempenhaeghe.nl. 2. CAPHRI School for Public Health and Primary Care, Maastricht University, Maastricht, The Netherlands; Department of Health Services Research, Maastricht University, Maastricht, The Netherlands; Department of Research & Development, Epilepsy Centre Kempenhaeghe, Heeze, The Netherlands. Electronic address: b.wijnen@maastrichtuniversity.nl. 3. CAPHRI School for Public Health and Primary Care, Maastricht University, Maastricht, The Netherlands; Department of Health Services Research, Maastricht University, Maastricht, The Netherlands; Department of Research & Development, Epilepsy Centre Kempenhaeghe, Heeze, The Netherlands. Electronic address: reina.dekinderen@maastrichtuniversity.nl. 4. MHENS, School for Mental Health and Neuroscience, Department of Psychiatry and Neuropsychology, Maastricht University Medical Centre, Maastricht, The Netherlands; Department of Neuropsychology and Psychopharmacology, Maastricht University, Maastricht, The Netherlands. Electronic address: c.vanheugten@maastrichtuniversity.nl. 5. CAPHRI School for Public Health and Primary Care, Maastricht University, Maastricht, The Netherlands; Department of Health Services Research, Maastricht University, Maastricht, The Netherlands; Trimbos Institute, Netherlands Institute of Mental Health and Addiction, Utrecht, The Netherlands. Electronic address: s.evers@maastrichtuniversity.nl. 6. Department of Research & Development, Epilepsy Centre Kempenhaeghe, Heeze, The Netherlands; Department of Neurology, Academic Centre for Epileptology, Epilepsy Centre Kempenhaeghe & Maastricht University Medical Centre, The Netherlands; MHENS, School for Mental Health and Neuroscience, Department of Psychiatry and Neuropsychology, Maastricht University Medical Centre, Maastricht, The Netherlands; School of Health Professions Education, Faculty of Health, Medicine and Life Sciences, Maastricht UMC+, The Netherlands. Electronic address: majoiem@kempenhaeghe.nl.
Abstract
INTRODUCTION: Self-management for people with epilepsy (PWE) should lead to shared decision-making and thus to adherence to the treatment plan. eHealth is an important way of supporting PWE in their self-management. METHOD: In this survey, we used a mixed method to explore the following: 1) which factors were monitored by PWE and how (using pen and paper or eHealth-tools), 2) how many PWE own a computer or smartphone, and 3) how do they perceive the use of eHealth. A consecutive series of 1000 PWE attending the outpatient clinic of a tertiary epilepsy center were asked to fill in a questionnaire. RESULTS: In comparison with the general population, fewer PWE owned a computer or smartphone. They were, however, more likely to self-monitor their health than other patients suffering from a chronic condition. Although PWE did not use eHealth-tools often, they perceived it as a user-friendly tool, promoting health behavior as well as adherence. On the other hand, problems with privacy and the perception that not everyone is able to use eHealth were considered as disadvantages by PWE. Promoting self-care was perceived as both an advantage and a disadvantage. It was seen as an advantage when PWE mentioned the option of eHealth-tools in order to gain insight into one's epilepsy. At the same time, it was seen as a disadvantage because it confronts PWE with their disease, which causes emotional stress. CONCLUSION: The high level of self-monitoring combined with a low usage of eHealth-tools seems to indicate that there is a need for a more tailored approach to stimulate the use of eHealth-tools by PWE. Further research should focus on this aspect, e.g., what PWE need in order to make more use of eHealth-tools in their self-care.
INTRODUCTION: Self-management for people with epilepsy (PWE) should lead to shared decision-making and thus to adherence to the treatment plan. eHealth is an important way of supporting PWE in their self-management. METHOD: In this survey, we used a mixed method to explore the following: 1) which factors were monitored by PWE and how (using pen and paper or eHealth-tools), 2) how many PWE own a computer or smartphone, and 3) how do they perceive the use of eHealth. A consecutive series of 1000 PWE attending the outpatient clinic of a tertiary epilepsy center were asked to fill in a questionnaire. RESULTS: In comparison with the general population, fewer PWE owned a computer or smartphone. They were, however, more likely to self-monitor their health than other patients suffering from a chronic condition. Although PWE did not use eHealth-tools often, they perceived it as a user-friendly tool, promoting health behavior as well as adherence. On the other hand, problems with privacy and the perception that not everyone is able to use eHealth were considered as disadvantages by PWE. Promoting self-care was perceived as both an advantage and a disadvantage. It was seen as an advantage when PWE mentioned the option of eHealth-tools in order to gain insight into one's epilepsy. At the same time, it was seen as a disadvantage because it confronts PWE with their disease, which causes emotional stress. CONCLUSION: The high level of self-monitoring combined with a low usage of eHealth-tools seems to indicate that there is a need for a more tailored approach to stimulate the use of eHealth-tools by PWE. Further research should focus on this aspect, e.g., what PWE need in order to make more use of eHealth-tools in their self-care.
Authors: Pegah Afra; Carol S Bruggers; Matthew Sweney; Lilly Fagatele; Fareeha Alavi; Michael Greenwald; Merodean Huntsman; Khanhly Nguyen; Jeremiah K Jones; David Shantz; Grzegorz Bulaj Journal: Front Hum Neurosci Date: 2018-05-01 Impact factor: 3.169
Authors: Allison A Lewinski; Abigail Shapiro; Jennifer M Gierisch; Karen M Goldstein; Dan V Blalock; Matthew W Luedke; Adelaide M Gordon; Hayden B Bosworth; Connor Drake; Jeffrey D Lewis; Saurabh R Sinha; Aatif M Husain; Tung T Tran; Megan G Van Noord; John W Williams Journal: Syst Rev Date: 2020-04-25